A new artificial intelligence model developed by researchers at Charité – Universitätsmedizin Berlin could transform how brain tumors are diagnosed, especially in cases where traditional biopsies are risky or impossible. The innovation comes in response to complex cases like that of a patient who first sought medical help for double vision. An MRI revealed a tumor located in a part of the brain that made surgical biopsy highly dangerous.
Confronted with such challenges, the team of researchers turned to an alternative approach. Instead of relying on tissue samples, they developed a method that uses an AI model to analyze the epigenetic fingerprint of tumors—chemical modifications in the genetic material that act like cellular memory and regulate gene activity. These fingerprints can be collected from body fluids such as cerebrospinal fluid, making the process minimally invasive.
Continue reading… “AI Breakthrough Offers Safe, Precise Brain Tumor Diagnosis Without Surgery”
